Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03480321 · ClinicalTrials.gov registry record · Phase 1
Pharmacokinetic Study of Once Daily PMR Compared to Twice Daily Cilostazol IR Tablets in Healthy Volunteers
A Phase 1 study of Intermittent Claudication, sponsored by Genovate Biotechnology Co., Ltd.,.
- Completed
- Registry status
- Phase 1
- Development phase
- 21
- Enrollment target
- 1
- Study location
NCT03480321 is a Phase 1 study of Intermittent Claudication that has completed, run by Genovate Biotechnology Co., Ltd.,. The registered enrollment target is 21 participants, below the 214-participant average among 11 other Intermittent Claudication trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03480321, a Phase 1 study of Intermittent Claudication, has completed, sponsored by Genovate Biotechnology Co., Ltd.,.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 21 participants
- Enrollment target
- 1
- Study location
Study Summary
The study is designed to evaluate the bioequivalency between the test formulations of extended-release tablet of cilostazol (PMR) administered once-daily and the reference formulation of immediate-release tablet of cilostazol (Cilostazol) administered twice-daily in normal healthy male and female subjects under fasting conditions.
Conditions Studied
Interventions
- DRUG Cilostazol 100 mg
- DRUG PMR 150 mg
- DRUG PMR 200 mg
Study Locations (1)
Missouri
- Bio-Kinetic Clinical Applications, LLC - Springfield
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2018-03-06 |
| Est. Completion | 2018-06-07 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03480321
The ClinicalTrials.gov registry entry for NCT03480321 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 214-participant average among 11 other Intermittent Claudication trials with a reported enrollment target (90% lower). The listed sponsor is Genovate Biotechnology Co., Ltd.,, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Intermittent Claudication appearing as the primary indexed condition, and to 3 interventions - of which Cilostazol 100 mg is the first listed.
NCT03480321 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.
Frequently Asked Questions
What is clinical trial NCT03480321 about?
NCT03480321 is a clinical study titled "Pharmacokinetic Study of Once Daily PMR Compared to Twice Daily Cilostazol IR Tablets in Healthy Volunteers". The study is designed to evaluate the bioequivalency between the test formulations of extended-release tablet of cilostazol (PMR) administered once-daily and the reference formulation of immediate-release tablet of cilostazol (Cilostazol) administered twice-daily in normal healthy male and female su...
What is the current status of trial NCT03480321?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 21 participants. The study started on 2018-03-06. Estimated completion is 2018-06-07.
What conditions does trial NCT03480321 study?
This clinical trial studies the following conditions: Intermittent Claudication.
What interventions are being tested in trial NCT03480321?
The interventions under investigation include: Cilostazol 100 mg (DRUG), PMR 150 mg (DRUG), PMR 200 mg (DRUG).
Who is sponsoring clinical trial NCT03480321?
This trial is sponsored by Genovate Biotechnology Co., Ltd.,, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03480321 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Intermittent Claudication
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Response to Exercise and Nitric Oxide in PAD
RECRUITING · Phase 2
-
Improving Mobility After Revascularization in Peripheral Artery Disease
RECRUITING · Phase 3
-
MetfOrmin BenefIts Lower Extremities With Intermittent Claudication
RECRUITING · Phase 3
-
The Chocolate Touch Study
ACTIVE NOT RECRUITING · NA
-
A Phase 2 Study of the Effects of Sapropterin Dihydrochloride on Symptomatic Peripheral Arterial Disease
COMPLETED · Phase 2
-
Distributed Registry
COMPLETED
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.